Why this matters: Three distinct signals converged on SMA this week. Short sellers are building positions fast. A key analyst just cut the stock. Yet options traders are nearly ignoring downside risk entirely.
Short interest hit 6.4% of free float on August 31. That's up 20.6% over the past week and 11.3% in a single day.
The lending market is tightening alongside. Availability fell 43% over the week to 235%. That's still within a normal range — roughly two shares available for every one already borrowed — but the direction is clear. A month ago, availability sat above 600%.
The ORTEX short score reflects the shift. It reached 64.6 on August 31, up from 54.7 just two weeks earlier. The short-score rank sits at the 11th percentile — meaning the stock ranks among the more heavily shorted names on a composite basis.
BMO Capital's Juan Sanabria downgraded SMA to Market Perform from Outperform on August 27, setting a $38 price target. The stock currently trades at $32.47.
One day later, Wells Fargo's Eric Luebchow moved in the opposite direction — raising his price target to $35 from $33, while keeping an Equal-Weight rating. That's a narrower gap to the current price, but no change in conviction.
The broader analyst picture remains constructive. Six analysts rate the stock Buy, two Hold, with a mean target of $37.07. The bear case points to acquisition constraints, capital cost headwinds, and competition for digital customer acquisition. Bulls see 12.3% FFO-per-share growth in 2025 and 16.3% in 2026 as the operating platform matures.
The put-call ratio hit 0.044 on August 31. That compares to a 20-day mean of 0.083. For most of July and early August, the ratio held near 0.10 — 23 calls traded for every put at current levels.
This is not a hedge-heavy market. Options positioning is near its most call-dominant readings in the past year. The 52-week low in the PCR is 0.0.
The tension is obvious. Short sellers are building positions while options traders barely price in downside. One of these camps is wrong.
Among top holders, Principal Global Investors added 540,189 shares as of July 31 — the largest recent build among disclosed holders. BlackRock added 273,964 shares over the same period. T. Rowe Price, the largest holder at 11.5% of shares, added 156,952 shares.
Goldman Sachs trimmed 236,793 shares, the only notable reduction in the top-15.
See the live data behind this article on ORTEX.
Open SMA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
